Core Viewpoint - Wuhan Heyuan Biotechnology Co., Ltd. successfully held an online investor communication meeting regarding its initial public offering (IPO) and listing on the Sci-Tech Innovation Board, emphasizing the importance of investor engagement and feedback for future growth [2][3] Company Overview - The company expressed gratitude to investors for their interest and questions during the IPO process, highlighting the role of various intermediaries and platforms in facilitating this communication [2] - The company aims to integrate constructive suggestions from investors into its management practices to enhance performance and build trust [2] Technology and Product Focus - Investors showed significant interest in the company's innovative "rice blood-making" technology and its commercialization progress, indicating a strong market potential [2] - The company is committed to advancing research and development (R&D) and industrialization processes to ensure sustainable growth [2] Corporate Governance and Market Communication - The company recognizes its responsibilities as a public entity and is dedicated to adhering to listing regulations, improving corporate governance, and maintaining transparent communication with the capital market [2] - The listing on the Sci-Tech Innovation Board is viewed as a critical milestone and the beginning of a new journey for the company [2] Future Outlook - The company looks forward to ongoing communication with investors and stakeholders, aiming to create value and share growth opportunities in the future [3]